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Introduction
Benign paroxysmal positional vertigo (BPPV) is a 
recurrent vestibular disorder characterized by rotator 
attacks lasting for a few seconds, which can be elicited 
by particular head movements. BPPV is the most 
common cause of vestibular disorder that accounts for 
approximately 20%-30% of all vertigo cases.1 One-year 
prevalence of the BPPV in a group of individuals aged 
more than 60 years old was about seven times higher than 
those aged 18 to 39 years.2
Most cases are idiopathic and secondary BPPV accounts 
for approximately 10% of cases.3 BPPV can be caused by 
either canalithiasis or cupulolithiasis and affects any of 
the three semicircular canals. In most cases, the posterior 
canal affects.4 Patient’s history, clinical examination, and 
specific clinical tests that expose each semicircular canal 
to gravity force and causing positional nystagmus, are the 
most common ways to diagnosis the BPPV.5
According to the previous studies, the absence of 
vestibular vitamin D receptor in mice results in vestibular 
dysfunctions.6 Patients with BPPV have lower bone 
mineral density. Based on the afro-mentioned, it is 
hypothesized that low serum vitamin D3 levels can cause 
BPPV in humans.7 
Serum calcium and serum vitamin D3 levels play an 
important role in improving bone mineral density and 
reducing the risk of bone fractures.8 Low levels of serum 
vitamin D3 are associated with low bone mass. It is well 
known that vitamin D3 supplementation reduces the 
risk of fractures in elders. In mice, vitamin D receptor 
deficiency is associated with balance impairment. 
Similarly, vitamin D deficiency may also predispose 
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Background: It is suggested that there is a positive association between vitamin D deficiency 
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humans to impaired balance/posture controls. Vitamin D 
is necessary for calcium absorption and bone hemostasis, 
so there is an association between biomarkers of bone 
turn over and the BPPV.9 
Based on what mentioned before, it is suggested that 
there is an association between serum vitamin D3 levels 
and the incidence of BPPV. The current study aimed to 
investigate the association between vitamin D3 deficiency 
and incidence of BPPV.
Materials and Methods
The current single centre observational case-control 
study was planned and conducted in the Department 
of Neurology, Choithram Hospital & Research Center 
(CHRC), Indore, MP, India, from January 2018 to 
December 2018. The patients presented at Outpatient 
Department (OPD) or admitted to the Department 
of Neurology, CHRC, were included in the study after 
obtaining informed written consent. Similar age group 
and sex-matched hospital-based controls were included 
in the study for comparison with cases.
All BPPV patients presenting to the OPD or emergency 
department or admitted in the wards of the Department 
of Neurology were subjected to a detailed history taking, 
thorough clinical examination, and investigations as per 
working proforma. All patients were under-go detailed 
evaluation for spontaneous nystagmus, head-shaking 
nystagmus, and positional nystagmus in addition to 
routine neurological examination. 
Inclusion criteria were defined as all consecutive patients 
with the diagnosis of idiopathic BPPV who were above 
the age of 18 with negative neurological status presented 
at the above mentioned centre from January 2018 to 
December 2018 were included. 
Exclusion criteria were as follows:
1. History of head and ear trauma, surgery or infectious 
diseases of the ear, maxillary sinuses, and neck areas 
during the preceding month of BPPV attack.
2. Patients with chronic renal, pulmonary, hematologic, 
gastrointestinal, cardiovascular diseases.
3. Taking supplementary calcium and vitamin D or 
taking medications that alter vitamin D metabolism 
(in the last 1 year).
4. Patients with a history or active case of inner ear 
diseases.
5. Patients with a typical history of BPPV without 
exhibit nystagmus on clinical tests.
6. Patients whose data is incomplete or denied for 
consent may be excluded.
Diagnosis of BPPV was based on the following criteria10: 
A. Recurrent rotator attacks of positional vertigo or 
vertigo provocation during the posture change. 
B. Duration of rotator attacks less than 1 minute.
C. Positional nystagmus of clinical maneuvers. 
D. Nystagmus not attributable to any other disorder.
To measure serum vitamin D3 levels, fasting morning 
venous blood sample was collected from all participants. 
The serum level of vitamin D3 was measured using The 
ARCHITECT STAT i1000SR immunoassay analyzer 
by the chemiluminescent microparticle immunoassay 
(CMIA) method. The following categorization was used 
for the vitamin D3 levels: normal (more than 75 nmol/L 
or 30 ng/mL); insufficient (50 to 74 nmol/L or 21 to 29 
ng/mL); and deficient (less than 50 nmol/L or 20 ng/mL). 
The study had not interfered with the ongoing treatment 
of the patients. 
Statistical Analysis
The sample size was calculated with OpenEPI software by 
using the Kelsey et al method, which indicated a sample 
size of 78 (i.e. 39 for the case and 39 for the control 
groups) (Odd ratio 3.80, ratio of case and control =1:1 and 
power =80%). Eventually, a total of 100 participants were 
sampled (50 for each group). Fifty cases that presented 
to the hospital with idiopathic BPPV diagnosis were 
included after applying inclusion criteria, and 50 control 
subjects were chosen from age and sex-matched patients 
without BPPV who attended the neurology OPD or 
other healthy persons who come for medical check-up or 
hospital staffs agreed to participate in the current study.
Data were analyzed using SPSS software. χ2 test was used 
for categorical variables. Student t-test was used for the 
unpaired parametric data. The ANOVA test was used for 
>2 groups parametric data. The Mann Whitney U test 
was applied for continuous variables. The Kruskal-Wallis 
test was applied to compare variables when more than 2 
groups were available for non-parametric data. Pearson’s 
correlation equation and Spearman’s Rho method were 
used in accordance with the variables group.
Results
The current clinical study was conducted at CHRC, 
Indore, MP, India, from January 2018 to December 2018. 
In total 100 patients were participated (50 in each group). 
Data were collected using a questionnaire.
The prevalence of BPPV was higher among those 
aged 50 to 70 years (64%). Most of the patients with 
BPPV were females (60%). Out of 50 patients, the 
prevalence of posterior canal, lateral canal, and anterior 
canal involvement were 32 (64%), 17 (34%), and 1 (2%), 
respectively. Right and left side involvement was found in 
28(56%) and 22(44%) patients, respectively (Table 1).
72 (72%) participants had vitamin D deficiency (40% 
in the case group and 32% in the controls group). The 
difference between both groups was statistically significant 
(P value = 0.03) (Table 2). The mean age of females was 
higher than males, and mean vitamin D levels were higher 
in males in comparison to females, but the difference was 
not statistically significant (P value = 0.05) (Table 3).
32 (64%) patients had posterior canal involved, that 20 
Dhameliya et al
Int Clin Neurosci J. Vol 7, No 3, Summer 2020124 journals.sbmu.ac.ir/Neurosciencehttp
(40%) of them were females and 12 (24%) were males. 
Besides, in both groups, the posterior canal was more 
involved. But canal involvement according to gender was 
not statistically significant (P value is >0.05). Left and 
right sides were affected in 22 (44%) and 28 (56%) of 
patients. Overall, the prevalence of left side involvement 
was higher among females, and right side involvement 
was more common among males. There was no significant 
difference based on gender (P value <0.05) (Table 4).
The mean age of participants in the case and control 
groups was 57.8 and 57.3 years, respectively. Mean 
duration of symptoms was 3.9 days. The mean vitamin 
D level for case and control groups was 34.9 and 46.5 
nmol/L, respectively, and the difference was statically very 
significant (p-value = 0.01). The Mean value of serum 
calcium levels, phosphorus, alkaline phosphatase, & 
serum parathormone were almost similar in both groups, 
and the difference was not statistically significant (P value 
> 0.05) (Table 5).
Discussion
Most BPPV cases are idiopathic. Previous studies showed 
that bone mineral density is lower among BPPV patients. 
Many studies mentioned the association between 
vitamin D3 and low bone mass. Given this statement, we 
conducted the current study to investigate the association 
between idiopathic BPPV and vitamin D level.
BPPV was found to be more common in those aged 
51 to 70 years (64%). Patients’ age ranged from 36 to 90 
years, and for the control group, it ranged from 34 to 
90 years. The mean age for the case and control groups 
was 57.8 ( ± 12.2) and 57.3 ( ± 12.2) years, respectively. In 
cases, the female age (58.5 ± 9.6 years) was slightly higher 
than males (57.42 ± 13.8 years), but the difference was not 
statistically significant. Karataş et al reported that a mean 
age of 51.4 years for BPPV patients, which is consistent 
with the findings of the current study.11 Talaat et al also 
reported a mean age of 47.6 ± 9.1 years. They also found 
that the mean age of recurrent subjects (i.e. 48.3 [ ± 9.4] 
years) was higher than non-recurrent subjects 47 ( ± 8.9), 
which is in line with the current study.12 
In the case group, females (60%) were more affected 
than males (40%). In 64% of the patients, the posterior 
canal was affected (24% male and 40% female). Hence, in 
both groups, posterior canal was more involved. Among 
Table 1. Demographic and Clinical Characteristics of Cases and Controls
Characteristics Cases (%) Controls (%)
Age (y)
< 40 6 (12%) 6 (12%)
41-50 8 (16%) 8 (16%)
51-60 16 (32%) 16 (32%)
61-70 16 (32%) 16 (32%)
> 70 4 (8%) 4 (8%)
Gender
Female 30 (60%) 30 (60%)
Male 20 (40%) 20 (40%)
Site
Left 22 (44%) NA
Right 28 (56%) NA
Canal involvement
Posterior 32 (64%) NA
Lateral 17 (34%) NA
Anterior 1 (2%) NA
NA, not available.






Yes 40 (40%) 32 (32%) 72 (72%)
0.03No 10 (10%) 18 (18%) 28 (28%)
Total 50 (50%) 50 (50%) 100 (100%)
a Mann-Whitney U test.
Table 3. Correlation Between Mean Age, Vitamin D Level, and Gender
Characteristics Variable Male Female P Valuea










a Mann-Whitney U test.





Male 12 (24%) 7 (14%) 1 (2%) 20 (40%)
0.45Female 20 (40%) 10 (20%) 0 (0%) 30 (60%)
Total 32 (64%) 17 (34%) 1 (2%) 50
Site involvement
Left Right
Male 6 (12%) 14 (28%) 20 (40%)
0.05Female 16 (32%) 14 (28%) 30 (60%)
Total 22 (44%) 28 (56%) 50 (100%)
Table 5. Correlation of Mean Age, Duration, Vitamin D3 Level, Calcium, 
Phosphorus, ALP, and PTH Level in Between Cases and Controls
Characteristics Cases Controls P Value
Age (y), mean (SD) 57.8 (12.2) 57.3 (12.2) 0.8
Duration of symptom in days, mean (SD) 3.9 (3.1) NA
Vitamin D3 (nmol/L), mean (SD) 34.9 (15) 46.5 (27.5) 0.01
S. Ca2+, mean (SD) 9.2 (0.6) 9.2 (0.6) 0.99
Phosphorus, mean (SD) 3.5 (0.4) 3.4 (0.3) 0.1
ALP, mean (SD) 84.8 (18.5) 88.92 (16.4) 0.2
PTH, mean (SD) 31.5 (7.1) 30.7 (6.6) 0.5
ALP, alkaline phosphatase, PTH, parathyroid hormone.
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females, left side (32%) was more affected than the right 
side (28%), while in male patient’s right side (28%) was 
more affected as compared to the left side (12%), and the 
difference was statistically significant (P value = 0.05).
Talaat et al reported a higher percentage of females 
(65%) than males (35%), which is consistent with the 
current study. Rhim found that 72.85% were females and 
27.15% were males, which is comparable with the results 
of the current study.13 Yetiser and Ince reported that the 
prevalence of BPPV was 1.5 times higher among women.14 
In the current study, the highest impact was for the 
posterior canal followed by lateral canal, and the least 
affect was for the anterior canal. Jeong et al reported that 
the highest and lowest impacts were on the posterior 
canal (in 51% cases) and anterior canal.7 Katsarkas et al 
also found that BPPV of the posterior semicircular canal 
was more common than the horizontal semicircular 
canal.15 The current and previous studies suggested that 
the posterior Semi-circular canal was more involved, 
because it was more susceptible to gravity.
The right ear was more affected in the current study, 
which is comparable to the study conducted by von 
Brevern et al16 that reported more involvement of the 
right ear, due to sleeping in the right lateral decubitus 
position. Katsarkas et al15 reported 57.74% and 42.26% 
involvements for the right and left sides, respectively. 
The mean value of vitamin D for case and control groups 
was 34.9( ± 15) and 46.5( ± 27.5) nmol/L, respectively. The 
prevalence of vitamin D deficiency was 72% in the current 
study (40% for cases and 32% for controls).
Jeong et al found that serum level of vitamin D3 
was lower in BPPV patients (14.4 ± 8.4), both in male 
(16.2 ± 8.9) and female (13.4 ± 8.0). Han et al also found 
that on post- menopausal women the mean serum 
vitamin D3 levels were significantly lower in patients with 
primary BPPV than controls (19.1 ± 5.2 versus 22.5 ± 5.8, 
P value < 0.001).17 
Sen et al reported that mean serum vitamin D3 levels in 
patients with BPPV and healthy controls were 20.3 ± 12.2 
and 18 ± 10.1 ng/mL, respectively. The prevalence of 
vitamin D3 deficiency among the BPPV patients and 
controls was 76% and 42%, respectively. A statistically 
significant difference was observed in the mean serum 
vitamin D3 levels and the deficiency prevalence between 
the two groups.18 
Ca2+ and carbonate ions are of crucial importance for 
vertebrate otoconia production. Besides, Ca2+ is required 
to mineralize otoconia and to maintain any turnover in 
the otolith, because the otoconia has a dynamic state.19,20 
Sanyelbhaa and Sanyelbhaa noted that vitamin D3 
deficiency leads to the formation of abnormal otoconia in 
the inner ear, which results in otolith dysfunction of the 
inner ear.21 
Dynamic calcium uptake also causes otolith of utricle in 
the inner ear, and this process is well related to calcium-
binding proteins that are up-regulated by vitamin D3.22 
Vestibular dysfunction is observed in mice without the 
vestibular D3 receptor. It has been assumed that serum 
vitamin D3 deficiency leads to BPPV via deranged 
calcium metabolism in the vestibular organs of the inner 
ear.23
Decreased fixation of calcium may cause failures in 
the remodeling of the internal structures of the otoconia 
in the inner ear.24 This is consistent with a recent report 
that noted to significant and inverse association between 
serum vitamin D3 and markers of bone metabolism. The 
reported also noted that vitamin D3 supplementation may 
prevent and treat BPPV recurrences.25 We have posited 
that Vitamin D prophylaxis may prevent development 
of the idiopathic BPPV. Further studies are needed to 
demonstrate this clinical significance. 
Finally, the condition of forming abnormal otoconia 
as a result of deranged calcium metabolism may prepare 
the ground for the disease. We suggest that BPPV may 
be a sequel of low vitamin D and disturbed calcium 
homeostasis. In conclusion, there seems to be a positive 
association between BPPV and low serum levels of 
vitamin D3. Although it is thought that serum vitamin D3 
deficiency could play a major role in the pathogenesis of 
BPPV, meanwhile it could also be a trigger factor.
Conclusion
According to the findings of the current study, it can 
be concluded that there is a statistically significant 
association between serum vitamin D3 deficiency and 
idiopathic BPPV. Moreover, it can be considered that 
serum vitamin D3 deficiency may be a risk factor for the 
BPPV. Further studies, such as large randomized control 
trials or large case-control studies are advised to confirm 
or exclude the above findings.
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